CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SNYNF

venglustat (GZ402671)

Phase 2
Sanofi (SNYNF)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Oct '26
SNYNFPhase 2

venglustat (GZ402671) Phase 2 Est. Readout

venglustat (GZ402671)
Oct 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Gaucher Disease Type 1

View Full Landscape
Drug Information

Target Indication

Gaucher Disease Type 1

Clinical Trial

NCT02843035

Last updated: 3/12/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.